Document Detail

Pharmacologic Therapy for New York Heart Association Class IV Heart Failure.
MedLine Citation:
PMID:  21906245     Owner:  NLM     Status:  In-Data-Review    
Congest Heart Fail. 2011;17:213-219. © 2011 Wiley Periodicals, Inc. As the incidence of heart failure increases, the number of patients with advanced heart failure is anticipated to grow. Substantial progress in the treatment of heart failure has been achieved over the past few decades. Several classes of medications have been studied and found effective, including beta-blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers, aldosterone antagonists, vasodilators, digoxin, and inotropes. The evidence base for the use of these medications in the treatment of patients with New York Heart Association (NYHA) class IV heart failure is reviewed.
Marco A Caccamo; Peter M Eckman
Related Documents :
21931965 - In-hospital prognostic value of hemoglobin levels on admission in patients with acute s...
18752765 - Rational use of diuretics in acute decompensated heart failure.
2000775 - Future directions in vasodilator therapy for heart failure.
19954925 - Energetic myocardial metabolism and oxidative stress: let's make them our friends in th...
23761565 - Unusually located left ventricular outflow myxoma: a brief review of the literature.
12691375 - A review of the guardian trial results: clinical implications and the significance of e...
Publication Detail:
Type:  Journal Article     Date:  2011-07-21
Journal Detail:
Title:  Congestive heart failure (Greenwich, Conn.)     Volume:  17     ISSN:  1751-7133     ISO Abbreviation:  Congest Heart Fail     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9714174     Medline TA:  Congest Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  213-9     Citation Subset:  IM    
Copyright Information:
© 2011 Wiley Periodicals, Inc.
From the Division of Cardiovascular Disease, Department of Cardiology, University of Minnesota Medical Center, Minneapolis, MN.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Multivariate risk scores and patient outcomes in advanced heart failure.
Next Document:  Device therapy in advanced heart failure: what to put in and what to turn off: remote telemonitoring...